WA SB5326

Establishes an emergency insulin program beginning January 1, 2026, allowing eligible Washington residents to access one 30-day supply of insulin per 12-month period for a maximum out-of-pocket cost of $10

Eligibility requires: Washington residency, a valid prescription, less than a seven-day supply of insulin available, and no existing coverage that caps insulin cost-sharing at $35 or less per 30-day supply

Network pharmacies dispense insulin via electronic voucher and receive reimbursement from the prescription drug purchasing consortium within 30 days; manufacturers are invoiced quarterly and must pay within 30 days

Manufacturers that fail to remit payment face fines up to $10,000 per violation, with collected fines deposited into the state health care affordability account

Health Care Authority must publish information about manufacturer patient assistance programs alongside the emergency insulin program on its website